Updated Recommendations for Use of the Janssen COVID-19 Vaccine Updated Recommendations for Use of the Janssen COVID-19 Vaccine
ACIP has reaffirmed its interim recommendation for use of the Janssen COVID-19 vaccine, with an included warning that rare clotting events might occur after vaccination among women aged 18-49 years.Morbidity & Mortality Weekly Report
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Public Health & Prevention Journal Article Source Type: news
More News: COVID-19 | Intensive Care | International Medicine & Public Health | Vaccines | Warnings | Women